Document is current
Any future updates will be listed below
-
Authors
Frändemark, Åsa
Törnblom, Hans
Simrén, Magnus
Jakobsson, Sofie
-
Funding
Funding for this research was provided by:
The Swedish Research Council (13409, 21691, 21692)
AFA Försäkring (dnr 190087)
The Faculty of Medicine, Sahlgrenska Academy, University of Gothenburg
Centre for Person-Centred Care (GPCC), Sahlgrenska Academy, University of Gothenburg
University of Gothenburg
- License Information
-
More Information
Article History
Received: 9 November 2021
Accepted: 15 February 2022
First Online: 19 February 2022
Declarations
:
: The study was approved by The Regional ethical review board in Gothenburg (diary number 366-15) and followed the ethical principles of the Helsinki declaration. All participants gave their verbal and written informed consent before the start of any study related procedures.
: Not applicable.
: ÅF and SJ have no competing interests. HT has served as Consultant/Advisory Board member for Allergan, Almiral and Shire. MS has served as a Consultant/Advisory Board member for Danone Nutricia Research, Ironwood, Menarini, Biocodex, Genetic Analysis AS, Glycom, Tillotts, Arena, Kyowa Kirin, Adnovate, and Atnahs Pharma, and as a speaker for Tillotts, Menarini, Kyowa Kirin, Takeda, Shire, Biocodex, Alimentary Health, AlfaSigma, Sanofi and Falk Foundation.
